Substituted indazole compounds as RORgammaT inhibitors and uses thereof
US10287272B2 · kind B2 · utility
2Cited by
46References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2016 |
| Grant date | May 14, 2019 |
| Priority date | — |
| Expiry date | Oct 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds according to Formula (I) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment o RORgammaT-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.